LAS VEGAS and WEBSTER, Texas, Oct. 10, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced positive clinical outcomes for its SUPERB pivotal clinical trial of its SUPERA® Peripheral ...
New Indications for Self-Expanding Device Address Broad Area of Peripheral Artery Disease MINNEAPOLIS --Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic ...
Late-Breaking Data Presented at Vascular InterVentional Advances (VIVA) 2012 Conference in Las Vegas
LAS VEGAS and WEBSTER, Texas, Oct. 10, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced positive clinical outcomes for its SUPERB pivotal clinical trial of its SUPERA® Peripheral ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In a session focused on lower-extremity intervention in superficial femoral artery and popliteal ...
Patients with superficial femoral/popliteal lesions experience significant and sustained improvements out to 3 years with a self-expanding nitinol stent. Updated data from the STROLL trial, presented ...
MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass Inc, a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD), announced today that they received ...
November 21, 2011 (New York, New York) — Three-year follow-up of the RESILIENT trial has shown that the LifeStent vascular stent (Bard Peripheral Vascular) leads to durable benefits and clinical ...
Please provide your email address to receive an email when new articles are posted on . Femoral-popliteal bypass was associated with a significantly higher reintervention rate than stenting in a ...
New Johns Hopkins research suggests that people who undergo minimally invasive placement of stents to open clogged leg arteries are significantly less likely than those who have conventional bypass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results